02 9487 9111
The University of Sydney Avondale College of Higher Education

Sydney Adventist Hospital
« View pages

Clinical Specialties - Cancer

Haematological Cancer Clinical Trials


Randomised double blind placebo controlled phase 3 study of the Bruton's Tyrosine Kinase Inhibitor PCI 32765 (Ibrutinib) in combination with either Bendamustine and Rituximab or Rituximab, Cyclophosphamide , Doxorubicin, Vincristine and Prednisone (RCHOP) in subjects with previously treated indolent NHL



An Australian, phase II, multicentre, randomised, study investigating safety and efficacy for dose reduced fludarabine, cyclophosphamide and i.v. obinutuzumab (G-FC3) versus oral chlorambucil and i.v. obinutuzumab (G-Clb) in previously untreated, comorbid (CIRS score ≥6), elderly (≥65 years old) patients with chronic lymphocytic leukaemia (CLL)


UNITY - Recruiting

Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma


Back to Top

Sydney Adventist Hospital Clinical Specialties and Services